COMMUNIQUÉS West-GlobeNewswire

SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide
11/06/2025
IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its [...]
KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders
11/06/2025
RIYADH, Saudi Arabia, June 11, 2025 (GLOBE NEWSWIRE) -- In a landmark medical achievement, King Faisal Specialist Hospital & Research Centre (KFSHRC) has become the first institution in the Middle East to [...]
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
11/06/2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Shareholders approve all proposed resolutions EINDHOVEN, The Netherlands, June 11, [...]
PAT (ALPAT) : Attribution gratuite de bons de souscription d'actions remboursables au bénéfice de tous les actionnaires de la Société
11/06/2025
Vandœuvre-lès-Nancy, le 11 juin 2025 – 19 : 00 (CET) Communiqué de presse Pour diffusion immédiate Attribution gratuite de bons de souscription d'actions remboursables au bénéfice de tous les actionnaires de la Société [...]
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025
11/06/2025
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025 NANTES, France, June 11, 6:30 PM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the cancellation of the convening of the [...]
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025
11/06/2025
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025 NANTES, France, 11 juin 2025, 18 heures 30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce l'annulation de la [...]
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
11/06/2025
CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of [...]
Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders
11/06/2025
Leiden, the Netherlands, June 11, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all [...]
Centre for Neuro Skills Unveils New Website Design to Better Serve Brain Injury Patients and Their Families
11/06/2025
BAKERSFIELD, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Centre for Neuro Skills (CNS), a leader in traumatic brain injury and stroke rehabilitation services, today announced the launch of its completely redesigned [...]
ACHC and BOC Partner to Support DMEPOS Suppliers Amid Market Changes
11/06/2025
CARY, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- In response to recent regulatory developments, the Accreditation Commission for Health Care (ACHC) and the Board of Certification/Accreditation (BOC) have established a [...]
CLSI partners with LymeX Diagnostics Prize to support Phase 4 team advancing Lyme disease diagnostics
11/06/2025
MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Clinical & Laboratory Standards Institute (CLSI) is proud to announce its partnership with LymeX Diagnostics Prize to support teams entering Phase 4 of the competition [...]
Gapin Institute and Bauman Medical Announce Strategic Partnership – “Peak Launch: Personalized Longevity and Hair Optimization—powered by Gapin Institute for Bauman Medical”
11/06/2025
BOCA RATON, Fla. and SARASOTA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- The Gapin Institute for Precision Medicine, a global leader in longevity, and Bauman Medical, a global leader in hair restoration and scalp health, [...]
Cabaletta Bio Announces Pricing of Public Offering of Securities
11/06/2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted [...]
Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered robotics
11/06/2025
Clinical progress, industrial partnerships, and global recognition drive momentum in rehabilitation, personal mobility, and humanoid robotics. New agreement with Renault Group accelerates commercialization and advances [...]
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
11/06/2025
U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support licensure Advisory Committee meeting scheduled for July 30, 2025 Mid-cycle meeting recently [...]
Moleculin Participates in Virtual Investor “What This Means” Segment
11/06/2025
Globally recognized Oncology Key Opinion Leader, Brian Andrew Van Tine, MD, PhD, discusses the positive topline results from the U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue [...]
Project 55 Launches Free Mental Health First Responder Training for Public Use
11/06/2025
Evidence-informed course equips non-professionals to respond to mental health crises with practical, scalable skills Project 55 Logo LADERA RANCH, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Project 55, a nonprofit [...]
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
11/06/2025
-- Femasys continues to expand access and market share for its first-line infertility treatment option, FemaSeed ® -- ATLANTA, June 11, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical [...]
Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress
11/06/2025
All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR); first patient to reach 1-year follow-up continues in drug- [...]

Pages